Columbus

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Cerebral palsy1 trial
• Depression1 trial
• Dystonia1 trial
• Huntington's disease1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• Neurocrine Biosciences3 trials

Closed trials

• Completed

  Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

  NCT05206513· Phase 3· Neurocrine Biosciences· Source

• Completed

  Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

  NCT05203341· Phase 2· Neurocrine Biosciences· Source

• Terminated

  Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

  NCT04400331· Phase 3· Neurocrine Biosciences· Source